VAN DER GIEZEN

Recently, we have started working on projects focussing on Alzheimer's disease. The projects include dietary measures to improve cognitive abilities, but also the early identification of people at risk of Alzheimer's disease. We are involved in several funded projects, including a large European public-private partnership. We are determining the gut microbiome of large patient cohorts and will use machine learning and artificial intelligence approaches to identify new disease predictors.

Primary location: Stavanger Norway